Agency News from Centron, Jocoto and Harrison and Star

Share this article:
Centron won the agency of record assignment for Cephalon's AMRIX capsules as well as the medical education agency assignment for a new product being developed by Acorda Therapeutics.

Jocoto said it has won launch assignments from Abaxis' animal health unit, IntraPace, Luminous Medical, Relievant Medical and a minimally invasive back surgery company. The San Francisco-based medical agency said it has seen a 25%-30% increase in spend since the economic downturn began in 2009.

Harrison and Star was named agency of record for the launch of Incyte's Janus-Associated Kinase inhibitor currently known as INCB18424, a first-in-class compound that, if approved, could become the first drug indicated for myleofibrosis.

Share this article:
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.